Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Thyroid Carcinoma, Anaplastic × pegfilgrastim × 1 year × Clear all

Sponsor

Conditions

Hodgkin Disease 6 Breast Neoplasms 6 Lymphoma, Large B-Cell, Diffuse 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Lymphoma 4 Rhabdomyosarcoma 3 Lymphoma, Non-Hodgkin 3 Leukemia 3 Burkitt Lymphoma 3 Triple Negative Breast Neoplasms 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Neuroblastoma 2 Fallopian Tube Neoplasms 2 Carcinoma, Ovarian Epithelial 2 Urinary Bladder Neoplasms 1 Teratoma 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma, Ewing 1 Sarcoma 1 Renal Pelvis and Ureter Urothelial Carcinoma 1 Recurrence 1 Prostatic Neoplasms 1 Pheochromocytoma 1 Pain 1 Ovarian Neoplasms 1 Osteosarcoma 1 Neoplasms, Germ Cell and Embryonal 1 Neoplasms 1 Multiple Myeloma 1 Medulloblastoma 1

Interventions

trametinib 5 dabrafenib 5 pembrolizumab 2 cobimetinib 2 atezolizumab 2 Vemurafenib 2 Radiotherapy, Intensity-Modulated 2 Paclitaxel 2 zimberelimab 1 tislelizumab 1 surufatinib 1 selpercatinib 1 lenvatinib 1 fludarabine 1 cemiplimab 1 cabozantinib 1 aldesleukin 1 abemaciclib 1 Taxes 1 Nivolumab 1 Ipilimumab 1 Immunoglobulin G 1 Disulfides 1 Cyclophosphamide 1 CTLA-4 Antigen 1 Bevacizumab 1 Albumin-Bound Paclitaxel 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡